EDSA Edesa Biotech Inc
Company Analysis
Latest News
🟢 Edesa Biotech is trading 5% up in after-hours trading amid sector-driven biotech momentum
Edesa Biotech is trading 5% up at $5.00 in after-hours trading, with the move appearing primarily sector-driven amid biotech momentum and broader risk-on...
🟢 Edesa Biotech is trading 5.59% up today amid broad biotech-sector strength
Edesa Biotech is trading at $5.05, up 5.59%, amid strong biotech-sector momentum. - XBI rose 2.75% during regular trading, supporting a sector-driven...
🟢 Edesa Biotech is trading 6.28% up in pre-market with no confirmed catalyst
Edesa Biotech is trading at $5.08 (+6.28%) in pre-market without a confirmed catalyst. - No new company-specific announcement for September 2, 2026 was...
🟢 Edesa Biotech is trading 5.81% up today
Edesa Biotech is trading 5.81% up at $5.01, rebounding from its August 27 decline. - No new company-specific announcement explaining the September 1, 2026...
🟢 Edesa Biotech is trading 6% up today after rebounding from August 27 decline
Edesa Biotech is trading 6.06% up now at $4.90 after rebounding from the August 27 decline. - No new company-specific announcement explaining the August 31...
🟢 Edesa Biotech is trading 5.43% up today; catalyst remains unclear
Edesa Biotech is trading 5.43% up at $4.85, rebounding after recent financing news, although causation is unconfirmed. - Shares rebounded from the August 27...
🟢 Edesa Biotech is trading 8.7% up in after-hours trading with catalyst still uncertain
Edesa Biotech is trading at $5.00 (+8.70%) in after-hours trading, amid broader market strength while the catalyst remains uncertain. - No identified...
🔴 Edesa Biotech is trading 5.87% down today amid recent financing overhang
Edesa Biotech is trading at $4.65, with a -5.87% change amid a recent financing overhang. - No new company-specific announcement explaining the August 27...
🟢 Edesa Biotech is trading 6.3% up in after-hours trading after Velan Capital disclosed a 9.99% stake
Edesa Biotech is trading 6.28% up at $5.25 after Velan Capital disclosed a 9.99% stake, improving investor sentiment following recent financing pressure. -...
🟢 Edesa Biotech is trading 10% up today after Velan Capital disclosed a 9.99% stake
Edesa Biotech is trading at $4.91, up +10.22%, as Velan Capital’s 9.99% stake disclosure boosts sentiment after selling pressure tied to the $25 million public...
🟢 Edesa Biotech is trading 6.29% up today after Velan Capital disclosed a 9.99% stake
Edesa Biotech is trading at $4.73 (+6.29%) following Velan Capital’s disclosure of a 9.99% stake with warrant exposure after purchasing shares in the...
🟢 Edesa Biotech soars 5% in after-hours as major investor boosts stake following offering
Edesa Biotech is trading 5.39% up at $4.69 after rebounding from selling linked to its $25 million public offering. * Velan Capital disclosed a 9.99% stake...
🟢 Edesa Biotech is trading 5.45% up today after rebounding from $25 million offering-driven selling
Edesa Biotech is trading at $4.64 with a +5.45% gain as it rebounds from heavy selling triggered by its $25 million public offering. - The financing was...
🟢 Edesa Biotech is trading 6% up in after-hours trading after August 20 offering pricing
Edesa Biotech is trading at $4.67, up +6.14%, after rebounding from recent selling tied to its August 20, 2026, $25 million underwritten offering. - Financing...
🟢 Edesa Biotech is trading 5% up in pre-market after August 20 $25 million offering pricing
Edesa Biotech is trading 5.19% up now at $4.66 after rebounding following the August 20 pricing of its $25 million underwritten public offering. - The...
🟢 Edesa Biotech is trading 5% up in after-hours trading following $25 million offering priced at $5.50
Edesa Biotech is trading at $4.67 (+5.42%) after rebounding in after-hours trading on August 21, 2026, following a sharp regular-session decline and the...
Edesa Biotech's $25 Million Cash Grab Keeps the Lights On, but Can Diluted Shareholders Still Win the Vitiligo Bet?
Shares of Edesa Biotech tumbled 10% to $4.28 after the Toronto-based clinical-stage drugmaker priced a $25 million underwritten public offering — a deal that...
🔴 Edesa Biotech is trading 10.03% down today after pricing a $25 million underwritten offering
Edesa Biotech is trading at $4.28, down 10.03%, after pricing a $25 million underwritten public offering. - Financing includes 3,870,500 shares and up to...
🔴 Edesa Biotech is trading 6.3% down today after pricing $25 million offering
Edesa Biotech is trading at $4.46, down -6.30% after pricing a $25 million underwritten public offering of shares, pre-funded warrants, and accompanying...
🟢 Edesa Biotech is trading 5% up in pre-market after pricing a $25 million underwritten offering
Edesa Biotech is trading at $5.00 (+5.04%) after pricing a $25 million underwritten public offering on August 20, 2026. - The financing includes 3.87 million...